471 related articles for article (PubMed ID: 22913675)
1. Tangier disease: epidemiology, pathophysiology, and management.
Puntoni M; Sbrana F; Bigazzi F; Sampietro T
Am J Cardiovasc Drugs; 2012 Oct; 12(5):303-11. PubMed ID: 22913675
[TBL] [Abstract][Full Text] [Related]
2. Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations.
Mott S; Yu L; Marcil M; Boucher B; Rondeau C; Genest J
Atherosclerosis; 2000 Oct; 152(2):457-68. PubMed ID: 10998475
[TBL] [Abstract][Full Text] [Related]
3. The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease.
Neufeld EB; Stonik JA; Demosky SJ; Knapper CL; Combs CA; Cooney A; Comly M; Dwyer N; Blanchette-Mackie J; Remaley AT; Santamarina-Fojo S; Brewer HB
J Biol Chem; 2004 Apr; 279(15):15571-8. PubMed ID: 14747463
[TBL] [Abstract][Full Text] [Related]
4. Cellular cholesterol efflux in heterozygotes for tangier disease is markedly reduced and correlates with high density lipoprotein cholesterol concentration and particle size.
Brousseau ME; Eberhart GP; Dupuis J; Asztalos BF; Goldkamp AL; Schaefer EJ; Freeman MW
J Lipid Res; 2000 Jul; 41(7):1125-35. PubMed ID: 10884295
[TBL] [Abstract][Full Text] [Related]
5. Restoration of endothelial function by increasing high-density lipoprotein in subjects with isolated low high-density lipoprotein.
Bisoendial RJ; Hovingh GK; Levels JH; Lerch PG; Andresen I; Hayden MR; Kastelein JJ; Stroes ES
Circulation; 2003 Jun; 107(23):2944-8. PubMed ID: 12771001
[TBL] [Abstract][Full Text] [Related]
6. Hepatic ABCA1 and VLDL triglyceride production.
Liu M; Chung S; Shelness GS; Parks JS
Biochim Biophys Acta; 2012 May; 1821(5):770-7. PubMed ID: 22001232
[TBL] [Abstract][Full Text] [Related]
7. Current Diagnosis and Management of Tangier Disease.
Koseki M; Yamashita S; Ogura M; Ishigaki Y; Ono K; Tsukamoto K; Hori M; Matsuki K; Yokoyama S; Harada-Shiba M
J Atheroscler Thromb; 2021 Aug; 28(8):802-810. PubMed ID: 33994407
[TBL] [Abstract][Full Text] [Related]
8. Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux.
Cheung MC; Mendez AJ; Wolf AC; Knopp RH
J Clin Invest; 1993 Feb; 91(2):522-9. PubMed ID: 8432861
[TBL] [Abstract][Full Text] [Related]
9. Hepatic ATP-binding cassette transporter A1 is a key molecule in high-density lipoprotein cholesteryl ester metabolism in mice.
Singaraja RR; Stahmer B; Brundert M; Merkel M; Heeren J; Bissada N; Kang M; Timmins JM; Ramakrishnan R; Parks JS; Hayden MR; Rinninger F
Arterioscler Thromb Vasc Biol; 2006 Aug; 26(8):1821-7. PubMed ID: 16728652
[TBL] [Abstract][Full Text] [Related]
10. Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I.
Timmins JM; Lee JY; Boudyguina E; Kluckman KD; Brunham LR; Mulya A; Gebre AK; Coutinho JM; Colvin PL; Smith TL; Hayden MR; Maeda N; Parks JS
J Clin Invest; 2005 May; 115(5):1333-42. PubMed ID: 15841208
[TBL] [Abstract][Full Text] [Related]
11. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
[TBL] [Abstract][Full Text] [Related]
12. Tangier disease four decades of research: a reflection of the importance of HDL.
Kolovou GD; Mikhailidis DP; Anagnostopoulou KK; Daskalopoulou SS; Cokkinos DV
Curr Med Chem; 2006; 13(7):771-82. PubMed ID: 16611066
[TBL] [Abstract][Full Text] [Related]
13. Cellular phospholipid and cholesterol efflux in high-density lipoprotein deficiency.
Marcil M; Bissonnette R; Vincent J; Krimbou L; Genest J
Circulation; 2003 Mar; 107(10):1366-71. PubMed ID: 12642355
[TBL] [Abstract][Full Text] [Related]
14. A novel splicing mutation in the ABCA1 gene, causing Tangier disease and familial HDL deficiency in a large family.
Maranghi M; Truglio G; Gallo A; Grieco E; Verrienti A; Montali A; Gallo P; Alesini F; Arca M; Lucarelli M
Biochem Biophys Res Commun; 2019 Jan; 508(2):487-493. PubMed ID: 30503498
[TBL] [Abstract][Full Text] [Related]
15. POPC/apoA-I discs as a potent lipoprotein modulator in Tangier disease.
Uehara Y; Tsuboi Y; Zhang B; Miura S; Baba Y; Higuchi MA; Yamada T; Rye KA; Saku K
Atherosclerosis; 2008 Mar; 197(1):283-9. PubMed ID: 17560579
[TBL] [Abstract][Full Text] [Related]
16. Clinical variant of Tangier disease in Japan: mutation of the ABCA1 gene in hypoalphalipoproteinemia with corneal lipidosis.
Ishii J; Nagano M; Kujiraoka T; Ishihara M; Egashira T; Takada D; Tsuji M; Hattori H; Emi M
J Hum Genet; 2002; 47(7):366-9. PubMed ID: 12111371
[TBL] [Abstract][Full Text] [Related]
17. Tangier disease caused by compound heterozygosity for ABCA1 mutations R282X and Y1532C.
Cameron J; Ranheim T; Halvorsen B; Kulseth MA; Leren TP; Berge KE
Atherosclerosis; 2010 Mar; 209(1):163-6. PubMed ID: 19765707
[TBL] [Abstract][Full Text] [Related]
18. Tangier disease and ABCA1.
Oram JF
Biochim Biophys Acta; 2000 Dec; 1529(1-3):321-30. PubMed ID: 11111099
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol efflux regulatory protein, Tangier disease and familial high-density lipoprotein deficiency.
Hayden MR; Clee SM; Brooks-Wilson A; Genest J; Attie A; Kastelein JJ
Curr Opin Lipidol; 2000 Apr; 11(2):117-22. PubMed ID: 10787172
[TBL] [Abstract][Full Text] [Related]
20. Differential phospholipid substrates and directional transport by ATP-binding cassette proteins ABCA1, ABCA7, and ABCA4 and disease-causing mutants.
Quazi F; Molday RS
J Biol Chem; 2013 Nov; 288(48):34414-26. PubMed ID: 24097981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
